Practical approach to the identification of clinically relevant Enterococcus species

Diagnostic Microbiology and Infectious Disease

Volumn 34, Issue 3, 1999, Pages 165-171

  Willey, Barbara M ^a   Jones, Ronald N ^b   McGeer, Allison ^a   Witte, Wolfgang ^c   French, Gary ^d   Roberts, Richard B ^e   Jenkins, Stephen G ^f   Nadler, Harriette ^g   Low, Donald E ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF IOWA   (United States)

^c ROBERT KOCH INSTITUTE   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e WEILL CORNELL MEDICAL CENTER   (United States)

^f CAROLINAS MEDICAL CENTER   (United States)

^g SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; DIAGNOSTIC ERROR; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FERMENTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TECHNIQUE;

EID: 0033041058     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00032-2     Document Type: Article

References (42)

1. Barry AL, Fuchs PC, Brown SD (1997) Provisional interpretive criteria for quinupristin-dalfopristin susceptibility tests. J Antimicrob Chemother 39(Suppl A):87-92.
2. Blacklock A, Willey BM, Ontario VRE Surveillance Study, Phillips R, McGeer A, Low DE (1996) Prevalence survey for vancomycin-resistant enterococci (VRE) in Ontario Hospitals. In: Proceedings of the 36th ICAAC, September 15-18, 1996, New Orleans, Louisiana, USA, Abstr # J4.
3. Boyce JM (1997) Vancomycin-resistant enterococcus: Detection, epidemiology and control measures. In: Nosocomial Infections, Infect Dis Clinics of North America 11:367-384.
4. Centers for Disease Control and Prevention (1993) Nosocomial enterococci resistant to vancomycin-United tates, 1989-1993. MMWR 42:597-599.
5. Centers for Disease Control and Preventation (1995) Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 44(RR-12):1-13.
6. Chen YC, Marshall SA, Winokur PL, Coffman L, Wilke WW, Murray PR, Spiegel CA, Pfaller MA, Doern GV, Jones RN (1998) Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan Dried Overnight Gram-Positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci. J Clin Microbiol 39: 2996-3001.
7. Clarke NC, Hill BC, Tenover FC (1994) Characterization of an Enterococcus raffinosis isolated with a vanB phenotype and vanA genotype. In Proceedings of the 94th general Meeting of the ASM, Las Vegas, Nevada, USA, abstr # A-III.
8. Collins LA, Malanoski GJ, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering Jr RC (1993) In vitro activity of RP 59500, and injectable streptogramin antibiotic, against vancomycin-resistant Gram-positive organisms. Antimicrob Agents Chemother 37:598-601.
9. Cormican MG, Johnson DM, Jones RN (1996) Activity of the quinupristin-dalfopristin combination (RP 59500, synercid®) tested against vancomycin-resistant Enterococcus species. Diagn Microbiol Infect Dis 24:59-60.
10. Degani O, Willey BM, MacMillan L, The Antimicrobial Resistance Study, McGeer A (1995) Characterization of Canadian Enterococcus spp. isolated from sterile sites. In Proceedings of the 95th ASM General Meeting, May 21-25, Washington, DC, USA, abstr # C-274.
11. Endtz HP, Van Den Braak N, Van Belkum A, Goessens WH, Kreft D, Stroebel AB, Verburgh HA (1998) Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol 36:592-594.
12. Facklam RR, Collins MD (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27:731-734.
13. Facklam RR, Sahm, DF (1995) Enterococcus. In Manual of Clinical Microbiology, Sixth Edition. Eds, Murray PR, et al: Washington, DC: ASM Press, pp. 308-314.
14. Fass RJ (1991) In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. Antimicrob Agents Chemother 35: 553-559.
15. Federal Register (1994) Preventing the spread of vancomycin resistance - report from the hospital infection control practices advisory committee. Fed Regist 59:25758-25763.
16. Jones RN, Ballow CH, Biedenbach DJ, Deinhart JA, Schentag JJ (1998) Antimicrobial activity of quinupristin-dalfopristin (RP59500, synercid®) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. Diagn Microbiol Infect Dis 30:437-451.
17. Jones RN, Erwin ME, Anderson SC (1995) Emerging multiply-resistant enterococci among clinical isolates. II Validation of the Etest to recognize glycopeptide-resistant strains. Diagn Microbiol Infect Dis 21:95-100.
18. Kapala MM, Armstrong-Evans M, Willey BM, Bernston A, Nusinowitz S, Low DE, McGeer A. (1998) Clonal dissemination of Enterococcus gallinarum in a long term care facility. In Proceedings of the International Conference of Emerging Infectious Disease, March 8-11, 1998, Atlanta, Georgia, USA, Abstr # P-24.
19. Landman D, Quale JM, Oydna E, Ditore V, Zaman M, Patel K, Suarina G, Huang W (1996) Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol 34: 751-752.
20. National Committee for Clinical Laboratory Standards (1997a) Methods for dilution antimicrobial susceptibility tests-Fourth Edition; Approved Standard. Document M7-A4. NCCLS, Wayne, PA, U.S.A.
21. National Committee for Clinical Laboratory Standards (1997) Performance standards for antimicrobial disk susceptibility tests-Sixth Edition: Approved Standard. Document M2-A6. NCCLS, Wayne, PA, U.S.A.
22. National Committee for Clinical Laboratory Standards (1998) Performance standards for antimicrobial susceptibility testing. Document M 100-S8. NCCLS, Wayne, PA, U.S.A.
23. National Committee for Clinical Laboratory Standards (1999) Performance standards for antimicrobial susceptibility testing. Document M 100-S9. NCCLS, Wayne, PA, U.S.A.
24. Patterson JE, Wanger A, Zscheck KK, Zervos MJ, Murray BE (1990) Molecular epidemiology of β-lactamase producing enterococci. Antimicrob Agents Chemother 34:302-305.
25. Ruoff KL (1995) Leuconostoc, Pediococcus, Stomatococcus, and miscellaneous Gram-positive cocci that grow aerobically. In Manual of Clinical Microbiology, Sixth edition. Eds, Murray PR, et al. Washington, DC: ASM Press, pp. 315-323.
26. Sader JS, Biedenbach D, Jones RN (1995) Evaluation of Vitek and API20S for species identification of enterococci. Diagn Microbiol Infect Dis 22:315-319.
27. Swenson JM, Clarke NC, Ferraro MJ, Sahm DF, Doern G, Pfaller M, Reller LB, Weinstein MP, Zabransky RJ, Tenover FC (1994) Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol 32:1700-1704.
28. Tenover FC (1998) Laboratory methods for surveillance of vancomycin-resistant enterococci. Clin Microbiol Newsletter 20:1-5.
29. Tenover FC, Swenson JM, O'Hare CM, Stocker SA (1995) Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol 33:1524-1527.
30. th ICAAC, September 15-18, New Orleans, Louisiana, U. S. A. abstr # D-105.
31. Toye B, Shymanski J, Bobrowska M, Woods W, Romatar K (1997) Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). J Clin Microbiol 35:3166-3170.
32. Tyrrell GJ, Bethune R, Willey BM, Low DE (1997) Species identification of enterococci via intergenic ribosomal PCR. J Clin Microbiol 35:1054-1060.
33. Verbist L, Verhaegen J (1992) Comparative in-vitro activity of RP 59500. J Antimicrob Chemother 30(Suppl A):39-44.
34. Werner G, Klare I, Witte W (1998) Quinupristin/ dalfopristin-resistant Enterococcus faecium: The link to animal husbandry. Eur J Clin Microbiol Infect Dis 17:401-402.
35. Wilke WW, Marshall SA, Coffman SL, Pfaller MA, Edmund MB, Wenzel RP, Jones RN (1997) Vancomycin-resistant Enterococcus raffinosis: Molecular epidemiology, species identification error, and frequency of occurrence in National Resistance Surveillance Program. Diagn Microbiol Infect Dis 28:43-49.
36. th ICAAC, September 28-October 1, Toronto, Ontario, Canada, abstr # D-121.
37. th ICAAC, September 24-27, San Diego, CA, U.S.A., abstr #D-016.
38. Willey BM, Kreiswirth BN, Simor AE, Scriver SR, Phillips A, Low DE (1992) Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol 30:1621-1624.
39. Willey BM, Kreiswirth BN, Williams G, Low DE (1993) Detection of ampicillin resistance in Enterococcus spp. by disk diffusion and two commercial automated system. Eur J Clin Microbiol Infect Dis 12:860-863.
40. th ASM General Meeting, May 19-23, 1996, New Orleans, Louisiana, USA, abstr # C-378.
41. Willey BM, Petrof EO, Louie L, Campbell I, Dick H, Richardson S, McGeer A, Low DE (1996c) Characterization of clinical isolates of non-motile Enterococcus gallinarum. In: Proceedings of the 36th ICAAC, September 15-18, New Orleans, Louisiana, USA, abstr # C18.
42. th ICAAC, September 15-18, 1996, New Orleans, Louisiana, USA, abstr # D31.